Collaboration will leverage the RaniPill® platform to explore oral delivery of PegBio's proprietary portfolio of novel obesity and metabolic disease molecules ~ ~ Agreement expands Rani's obesity fran ...

Weichai Power (HKG:2338) announced that its independently developed WP15 hydrogen direct-injection engine for heavy-duty vehicles has successfully ...

Community psychiatrist Dr. Chad Koyanagi spoke with HPR’s Lillian Tsang about his career and being recognized with a top ...

As scientists gain a deeper understanding of how the body’s immune system remembers pathogens it must fight, the paradigm for ...

The FDA's approval of vepdegestrant marks a groundbreaking shift in cancer therapy by introducing PROTAC technology for advanced breast cancer treatment.

News, recaps, highlights and winners from the Tokyo Paralympic Games on the night of Thursday, August 26 and morning of ...

Injuries force Michael Smith to pause season, missing European events and risking major qualification. Former world champion ...

NYSE: NSRX Lily: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The next ...

Awareness of all the ways prompt injection can be effected will help security teams spot a new generation of attacks.

Approval covers all current IV isatuximab indications and introduces the first oncology product labeled for both OBI and manual SC administration. IRAKLIA (NCT05405166) established noninferiority of ...

Sanofi (SNY) wins FDA approval for Sarclisa Escena, a subcutaneously-delivered version of its multiple myeloma therapy ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.